NCT04359212View on ClinicalTrials.gov

Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

June 30, 2020

Study Completion Date

July 31, 2020

Conditions
COVID-19 DiseaseThromboembolism, Venous
Interventions
DRUG

thromboprophylaxis with low-molecular-weight heparin or fondaparinux

thromboprophylaxis with low-molecular-weight heparin or fondaparinux

Trial Locations (1)

35138

Giuseppe Camporese, Padua

All Listed Sponsors
collaborator

Azienda Ospedaliera di Padova

OTHER

lead

Quovadis Associazione

OTHER

NCT04359212 - Increased Risk of VTE and Higher Hypercoagulability in Patients Recovered in ICU and in Medical Ward for COVID-19 | Biotech Hunter | Biotech Hunter